Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Rhabdomyosarcoma
100%
Novel Therapies
100%
IL-24
100%
PAX3-FOXO1
100%
Alveolar Rhabdomyosarcoma
85%
Knockdown
57%
Rhabdomyosarcoma Cells
42%
Tumor
28%
Cell Proliferation
28%
Overexpression
28%
Cell Migration
28%
Cell Survival
28%
Adenoviral
28%
Histone Deacetylase 5 (HDAC5)
28%
Clinical Trials
14%
Solid Tumors
14%
Poor Prognosis
14%
Tumor Growth
14%
RNA Interference
14%
Drug Therapy
14%
Interference Test
14%
Athymic nude Mice
14%
Patient Tumor
14%
RNA Sequencing (RNA-seq)
14%
Cytotoxic Drugs
14%
Sequencing Studies
14%
Tumor Weight
14%
Pax3
14%
Oncogenic Fusion Protein
14%
Biochemistry, Genetics and Molecular Biology
FOXO1
100%
Interleukin 24
100%
PAX3
100%
Cell Proliferation
28%
Cell Survival
28%
Cell Migration
28%
Histone Deacetylase 5
28%
Clinical Trial
14%
Cytokine
14%
Nude Mouse
14%
Carcinogenesis
14%
Tumor Progression
14%
RNAI
14%
Chimeric Protein
14%
Drug Therapy
14%
RNA Sequence
14%
Transcription Factor PAX3
14%
Medicine and Dentistry
Rhabdomyosarcoma
100%
Interleukin 24
100%
Cell Proliferation
28%
Cell Migration
28%
Cell Survival
28%
Tumor
28%
Histone Deacetylase 5
28%
RNA Sequence
14%
Solid Malignant Neoplasm
14%
Clinical Trial
14%
Neoplasm
14%
Tumor Progression
14%
Cytokine
14%
Carcinogenesis
14%
RNAI
14%
Cytotoxic Chemotherapy
14%
Chimeric Protein
14%
Transcription Factor PAX3
14%
Pharmacology, Toxicology and Pharmaceutical Science
Rhabdomyosarcoma
100%
Interleukin 24
100%
Histone Deacetylase 5
28%
Clinical Trial
14%
Neoplasm
14%
Solid Malignant Neoplasm
14%
Nude Mouse
14%
Tumor Growth
14%
Cytokine
14%
Carcinogenesis
14%
Cytotoxic Chemotherapy
14%
Chimeric Protein
14%
RNA-Sequencing
14%
Transcription Factor PAX3
14%